Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Permian Resources | PR | Jan 23, 2025 | 15.58 | -0.38 |
Permianville Royalty Trust Unit | PVL | Jan 23, 2025 | 1.47 | -3.29 |
PermRock Royalty Trust Unit | PRT | Jan 23, 2025 | 4.18 | +1.70 |
Perpetua Resources | PPTA | Jan 23, 2025 | 12.35 | +0.82 |
Perrigo | PRGO | Jan 23, 2025 | 24.75 | +2.91 |
Personalis | PSNL | Jan 23, 2025 | 6.15 | +9.82 |
Perspective Therapeutics | CATX | Jan 23, 2025 | 3.63 | +0.83 |
Petco Health And Wellness | WOOF | Jan 23, 2025 | 3.86 | +2.39 |
PetMed Express | PETS | Jan 23, 2025 | 4.97 | -0.60 |
Petroleo Brasileiro S.A.- Petrobras ADR | PBR | Jan 23, 2025 | 13.80 | -0.50 |
Petroleo Brasileiro S.A.- Petrobras ADR Pref | PBR-A | Jan 23, 2025 | 12.40 | -0.48 |
Petros Pharmaceuticals | PTPI | Jan 23, 2025 | 0.34 | +11.51 |
Pfizer | PFE | Jan 23, 2025 | 26.44 | +1.65 |
PG&E Pref A | PCG-X | Jan 23, 2025 | 42.40 | 0.00 |
Pgim Global High Yield Fund | GHY | Jan 23, 2025 | 13.00 | -0.15 |
Pgim High Yield Bond Fund | ISD | Jan 23, 2025 | 13.91 | +0.36 |
PGIM Short Duration High Yield Opportunities Fund | SDHY | Jan 23, 2025 | 16.59 | +0.61 |
Pharmaceutical ETF Market Vectors | PPH | Jan 23, 2025 | 86.86 | +1.14 |
PharmaCyte Biotech | PMCB | Jan 23, 2025 | 1.70 | +2.37 |
Pharming Group ADR | PHAR | Jan 23, 2025 | 9.29 | +2.20 |
Pharvaris | PHVS | Jan 23, 2025 | 19.32 | -1.13 |
Phathom Pharmaceuticals | PHAT | Jan 23, 2025 | 7.17 | +2.58 |
PhenixFIN | PFX | Jan 23, 2025 | 49.25 | +0.36 |
Pheton | PTHL | Jan 23, 2025 | 3.60 | -1.10 |
Phibro Animal Health A | PAHC | Jan 23, 2025 | 21.87 | +0.51 |
Philip Morris | PM | Jan 23, 2025 | 125.43 | +2.07 |
Philippines Invstb Mkt Idx MSCI Ishares | EPHE | Jan 23, 2025 | 24.68 | +0.16 |
Phillips 66 | PSX | Jan 23, 2025 | 122.62 | +3.43 |
Phillips Edison & Company | PECO | Jan 23, 2025 | 36.30 | +1.37 |
PHINIA | PHIN | Jan 23, 2025 | 50.31 | -1.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.